DMG MORI (GIL) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Solid Q3 performance amid challenging economic conditions, with positive feedback at AMB 2024 and continued focus on innovation and transformation strategy.
Sales revenues and order intake declined year-over-year due to subdued demand and delivery delays, but EBIT and EBIT margin improved.
Financial highlights
Order intake for the first nine months: €1,733.6 million, down 16% year-over-year; Q3 order intake: €505.0 million, down 16%.
Sales revenues for the first nine months: €1,604.3 million, down 11% year-over-year; Q3 sales: €500.1 million, down 18%.
EBIT for the first nine months: €149.0 million, up 7%; EBIT margin improved to 9.3% from 7.7%.
EAT for the first nine months: €18.3 million, down 82% due to discontinued operations; EAT from continuing operations: €110.2 million, up 7%.
Free cash flow for the first nine months: €-10.6 million, compared to €24.5 million last year.
Outlook and guidance
Order intake for 2024 expected between €2.2–2.3 billion (previously ~€2.3 billion).
Sales revenues forecasted at €2.2–2.3 billion (previously ~€2.4 billion).
EBIT guidance unchanged at around €200 million; free cash flow expected at €100 million (previously €150 million).
No significant recovery expected in Q4 due to ongoing delivery delays and subdued demand.
Latest events from DMG MORI
- Order intake rose 4% year-over-year, but sales and EBIT fell amid ongoing global uncertainties.GIL
Q4 202519 Mar 2026 - Order intake steady, but sales and earnings fell, leading to a downward revision in guidance.GIL
Q3 202530 Oct 2025 - Order intake and sales fell, but profitability and 2025 guidance remain solid.GIL
Q2 20251 Aug 2025 - Profitability rose despite lower sales, with a one-time Russian loss driving a group net loss.GIL
Q2 202413 Jun 2025 - EBIT margin rose to 11% as DMG MORI AG overcame market headwinds and Russian asset loss.GIL
Q4 20249 Jun 2025 - Order intake and sales dropped 15% year-over-year, but full-year guidance is reaffirmed.GIL
Q1 20256 Jun 2025